As IVIg alone is not sufficient to treat NF155+ CIDP and nerve hypertrophy responds poorly to immunotherapy after long disease duration (5), early introduction of combined therapy with corticosteroids and immunosuppressants is recommended. This evidence concerns the gene PMP22 and cardiac hypertrophy.